Company / Current Assets per Share
Processa Pharmaceuticals, Inc. Current Assets per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.53
FY2022
5-year range
$0.00 / $1.29
FY2018-FY2022
Trend
-58.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.53 over the past 6 years.
Based on SEC 10-K filings.
0.53 in FY2022.
Improved from $0.00 to $0.53 over the past 6 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current assets per share decreased 58.7% year-over-year.
- Peak current assets per share was recorded in FY2021.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.53 | -58.7% |
| FY2021 | $1.29 | +439746.9% |
| FY2016 | $0.00 | -96.9% |
| FY2015 | $0.01 | -79.7% |
| FY2014 | $0.05 | -83.2% |
| FY2013 | $0.28 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026